Multiple sclerosis: FDA reporting patterns
47,426 FDA FAERS reports mention Multiple sclerosis. 31,590 reports have a serious outcome flag.
Medicines named as suspect
- Natalizumab: 9,500 reports
- Interferon Beta-1a: 8,026 reports
- Dimethyl Fumarate: 5,498 reports
- Glatiramer: 2,850 reports
- Ocrelizumab: 2,812 reports
- Dalfampridine: 2,432 reports
- Fingolimod: 2,336 reports
- Teriflunomide: 2,053 reports
- Interferon Beta-1b: 1,561 reports
- Ofatumumab: 1,422 reports
- Diroximel: 1,084 reports
- Adalimumab: 929 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.